CymaBay Therapeutics, Inc.

Avoro Capital Advisors LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

11,111,111

Value ($000)

262,444

Weight

3.6%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	262,444	3.6%	11,111,111	12/31/2023
2023 Q3	11/14/2023	153,573	2.4%	10,300,000	9/30/2023
2023 Q2	8/14/2023	112,785	1.5%	10,300,000	6/30/2023
2023 Q1	5/15/2023	89,816	1.3%	10,300,000	3/31/2023
2022 Q4	2/14/2023	64,581	1.0%	10,300,000	12/31/2022
2022 Q3	11/14/2022	36,050	0.7%	10,300,000	9/30/2022
2022 Q2	8/15/2022	30,385	0.6%	10,300,000	6/30/2022
2022 Q1	5/16/2022	32,033	0.6%	10,300,000	3/31/2022
2021 Q4	2/14/2022	34,814	0.6%	10,300,000	12/31/2021
2021 Q3	11/15/2021	37,595	0.6%	10,300,000	9/30/2021
2021 Q2	8/16/2021	44,908	0.8%	10,300,000	6/30/2021
2021 Q1	5/17/2021	46,762	0.8%	10,300,000	3/31/2021
2020 Q4	2/16/2021	59,122	1.0%	10,300,000	12/31/2020
2020 Q3	11/16/2020	74,572	1.1%	10,300,000	9/30/2020
2020 Q2	8/14/2020	18,323	0.4%	5,250,000	6/30/2020
2020 Q1	5/15/2020	8,140	0.3%	5,500,000	3/31/2020
2019 Q4	2/14/2020	10,780	0.3%	5,500,000	12/31/2019